Open menu

Nanotechnology General News

The latest news from academia, regulators
research labs and other things of interest

Posted: Dec 06, 2011

NanoSight wins Technology World's 2011 Business Innovation Award

(Nanowerk News) NanoSight, leading manufacturers of unique nanoparticle characterization technology, are winners of this year's Technology World's 2011 Business Innovation Award in the category of Energy & Environment. These annual awards are sponsored by the PA Consulting Group.
Now in their 4th year, the Business Innovation Awards showcase the very best of British innovation. After receiving a record number of entries, NanoSight has been named winners in the Energy & Environment category in recognition of their position as world leading providers of instruments for the optical detection and real time analysis of sub-micron particles.
NanoSight CEO Jeremy Warren receives the 2011 Business Innovation Award from Vince Cable
NanoSight CEO Jeremy Warren receives the 2011 Business Innovation Award from Vince Cable, Secretary of State for Business, Innovation and Skills and President of the Board of Trade.
NanoSight's unique nanoparticle tracking analysis systems have enabled more than 400 research teams around the world to better understand the behaviour of materials on the sub-micron scale. It delivers the world's most versatile and proven multi-parameter nanoparticle analysis in a single instrument by visualizing, measuring and characterizing virtually all nanoparticles. Particle size, concentration, aggregation and zeta potential can all be analyzed while a fluorescence mode provides speciation of labeled particles. NanoSight provides real time monitoring of the subtle changes in the characteristics of particle populations with all of these analyses uniquely confirmed by visual validation.
Jeremy Warren, CEO of NanoSight, commented: "The products we sell are unique, and we estimate we are currently only in single digits in terms of percentage of market penetration. The recognition of this prestigious award further underscores our self-belief in that we are being successful in delivering cutting edge technology solutions in fields which impact directly on the quality of life. Applications that enable the production of better, more consistent vaccines to showing the ability to measure events that detect cancerous diseases earlier than ever before give us a lot of confidence for the coming years of more growth."
To find out about the company and to learn more about particle characterization using NanoSight's unique nanoparticle tracking analysis solutions, visit and register to receive the next issue of NanoTrail, the company's electronic newsletter.
About NanoSight
NanoSight delivers the world's most versatile and proven multi-parameter nanoparticle analysis in a single instrument.
NanoSight's "Nanoparticle Tracking Analysis" (NTA) detects and visualizes populations of nanoparticles in liquids down to 10 nm, dependent on material, and measures the size of each particle from direct observations of diffusion. Additionally, NanoSight measures concentration and a fluorescence mode differentiates suitably-labelled particles within complex background suspensions. Zeta potential measurements assess the surface charge on particles. NTA's particle-by-particle methodology goes beyond traditional light scattering and other ensemble techniques in providing high-resolution particle size distributions and validates data with information-rich video files of the particles moving under Brownian motion.
NanoSight's simultaneous multiparameter characterization matches the demands of complex biological systems, hence its wide application in development of drug delivery systems, of viral vaccines, and in nanotoxicology. This real-time data gives insight into the kinetics of protein aggregation and other time-dependent phenomena in a qualitative and quantitative manner. NanoSight has a growing role in biodiagnostics, being proven in detection and speciation of nanovesicles (exosomes) and microvesicles.
NanoSight has installed more than 400 systems worldwide with users including BASF, GlaxoSmithKline, Merck, Novartis, Pfizer, Proctor and Gamble, Roche and Unilever together with the most eminent universities and research institutes. NanoSight's technology is validated by 300+ third party papers citing NanoSight results, consolidating NanoSight's leadership position in nanoparticle characterization. For more information, visit
Source: NanoSight (press release)
Subscribe to a free copy of one of our daily
Nanowerk Newsletter Email Digests
with a compilation of all of the day's news.
If you liked this article, please give it a quick review on reddit or StumbleUpon. Thanks!
These articles might interest you as well: